pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›cytisinicline
drug · small molecule
save

cytisinicline

pre_registrationupdated 3mo ago
by $ACHV ACHIEVE LIFE SCIENCES, INC.🔗 ChEMBL
community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for nicotine dependence and 2 investigational indications.

targets

Neuronal acetylcholine receptor; alpha4/beta2

all catalysts(0)

nothing on the calendar yet

Trials studying cytisinicline

  • phase3Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E Cigarettesnot yet recruitingn=800
  • phase3A Study of Cytisinicline for Smoking Cessation in Adult Smokerscompletedn=810
  • phase3A Second Study of Cytisinicline for Smoking Cessation in Adult Smokerscompletedn=792
  • phase2A Study of Cytisinicline for Vaping Cessation in Adult Smokerscompletedn=160
  • phase3Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokerscompletedn=479
  • phase1Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dosecompletedn=44
  • phase1Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy Adult Smokerscompletedn=30
  • phase1Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy Smokerscompletedn=27
more trials →

News(0)

no news has mentioned this drug yet

trade names
Tabex
generic
cytisinicline
MOA
Neuronal acetylcholine receptor; alpha4/beta2 partial agonist
indication
Smoking Cessation
phase
pre_registration
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 57m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?